Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 844 in its research report dated July 28, 2021.
Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 848 in its research report dated January 27, 2021.
Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 813 in its research report dated October 28, 2020.
Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 2090 in its research report dated July 28, 2020.
Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 1028 in its research report dated May 19, 2020.
Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 745 in its research report dated November 21, 2018.
Centrum is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 910 in its research report dated October 04, 2018.
Centrum is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 960 in its research report dated May 17, 2018.
Centrum Research is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 940 in its research report dated January 15, 2018.
Motilal Oswal is bullish on Suprajit Eng has recommended buy rating on the stock with a target price of Rs 705 in its research report dated Februrary 10, 2016.
Brokerage house Firstcall Research is bullish on Aarti Drugs and has recommended buy rating on the stock with a target price of Rs 790 in its research report dated August 3, 2015.
Brokerage house Firstcall Research is bullish on Aarti Drugs and has recommended buy rating on the stock with a target price of Rs 240 in its January 06, 2014 research report.
Sunidhi Securities is bullish on Aarti Drugs (ADL) and has recommended buy rating on the stock with a price target of Rs 260 in its June 26, 2013 research report.
Sunidhi Securities is bullish on Aarti Drugs and has recommended buy rating on the stock with a target of Rs 210 in its April 09, 2013 research report.
Firstcall Research is bullish on Aarti Drugs and has recommended buy rating on the stock with a target of Rs 175 in its April 4, 2013 research report.